Results 131 to 140 of about 5,939 (161)
Some of the next articles are maybe not open access.
Benralizumab for eosinophilic granulomatosis with polyangiitis
Annals of the Rheumatic Diseases, 2023Benralizumab is effective in the treatment of eosinophilic asthma and is being investigated for the treatment of other eosinophil-associated diseases. Reports on the use of benralizumab for the treatment of eosinophilic granulomatosis with polyangiitis (EGPA) are limited to case reports and small case series.We conducted a multicentre, retrospective ...
Cottu, Adrien +25 more
openaire +2 more sources
Targeting Eosinophils in Eosinophilic Granulomatosis with Polyangiitis
New England Journal of Medicine, 2017Eosinophilic granulomatosis with polyangiitis, first described in the early 1950s by Dr. Jacob Churg and Dr. Lotte Strauss (hence the original name, the Churg–Strauss syndrome), is a rare condition that can affect many organ systems, most commonly the lung, with the majority of patients presenting with asthma symptoms, occasionally complicated by the ...
Djukanović, Ratko, O'Byrne, Paul
openaire +2 more sources
Eosinophilic granulomatosis with polyangiitis
Folia Otorhinolaryngologiae et Pathologiae RespiratoriaeEosinophilic granulomatosis with polyangiitis (EGPA) is a rare systemic disease in the group of ANCA-associated vasculitides, characterized by a combination of severe eosinophilic asthma, chronic rhinosinusitis, hypereosinophilia, and necrotizing vasculitis of small and medium-sized vessels.
Alexandra M. Nanzer +5 more
+4 more sources
Eosinophilic Granulomatosis With Polyangiitis
JAMA Dermatology, 2021Abraham M, Korman, Catherine G, Chung
openaire +2 more sources
Eosinophilic fasciitis in eosinophilic granulomatosis with polyangiitis
Rheumatology, 2023Ole Hudowenz +3 more
openaire +2 more sources
Eosinophilic Granulomatosis with Polyangiitis (Churg–Strauss)
Seminars in Respiratory and Critical Care Medicine, 2018AbstractEosinophilic granulomatosis with polyangiitis (EGPA), formerly called Churg–Strauss syndrome, is a systemic necrotizing vasculitis of small- and medium-size vessels, characterized by asthma and blood eosinophilia. EGPA typically occurs in patients with preexisting asthma, and involves the skin, lungs, and peripheral nerves.
Yann, Nguyen, Loïc, Guillevin
openaire +2 more sources
Benralizumab in eosinophilic granulomatosis with polyangiitis
Medicina Clínica, 2022Daniel, Laorden +2 more
openaire +2 more sources
Eosinophilic Granulomatosis With Polyangiitis: Newer Therapies
Current Rheumatology Reports, 2018Eosinophilic granulomatosis with polyangiitis (EGPA) is a systemic disseminated vasculitis associated with extravascular granulomas in patients suffering from asthma and tissue eosinophilia. Current therapies to achieve remission and prevent relapse include glucocorticoids and immunosuppressants like cyclophosphamide.With the right treatment, clinical ...
Erika P, Navarro-Mendoza +1 more
openaire +2 more sources
Aortitis in Eosinophilic Granulomatosis With Polyangiitis
JCR: Journal of Clinical Rheumatology, 2023Hirotaka, Yamamamoto +1 more
openaire +2 more sources
Cardiac involvement in eosinophilic granulomatosis with polyangiitis
Rheumatology International, 2017rad prikazuje zahvaćenost srca u ...
openaire +3 more sources

